Company Filing History:
Years Active: 2024-2025
Title: Marilyne Levy: Innovator in Fetal Heart Defect Detection
Introduction
Marilyne Levy is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical technology, particularly in the detection of fetal congenital heart defects. With a total of 3 patents to her name, her work is paving the way for advancements in prenatal care.
Latest Patents
Marilyne's latest patents focus on systems and methods for improving the detection of fetal congenital heart defects. One of her notable inventions involves the use of machine learning algorithms to analyze image data from fetal ultrasound examinations. This technology aids in the detection and diagnosis of critical heart defects by identifying morphological and flow abnormalities. The results are presented to clinicians with an overlay that highlights these abnormalities, allowing for better diagnosis and documentation of the ultrasound examination.
Another patent also addresses the detection of critical heart defects during fetal ultrasound examinations. This system analyzes image data to select frames that correspond to standard views recommended by fetal ultrasound guidelines. By utilizing machine learning algorithms, it detects morphological abnormalities indicative of critical congenital heart defects. The clinician can review the results with an overlay that identifies the abnormalities, enhancing the overall diagnostic process.
Career Highlights
Marilyne Levy is currently associated with Brightheart SAS, where she continues to innovate in the field of fetal health. Her work is instrumental in improving prenatal diagnostics, ultimately benefiting expectant parents and healthcare providers alike.
Collaborations
Marilyne collaborates with talented professionals in her field, including Bertrand Stos and Cécile Dupont. Their combined expertise contributes to the advancement of technologies aimed at enhancing fetal health diagnostics.
Conclusion
Marilyne Levy's contributions to the detection of fetal congenital heart defects through innovative technologies are noteworthy. Her patents reflect a commitment to improving prenatal care and diagnostics, making a significant impact in the medical field.